Doctor of Podiatric Medicine Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Mark Razzante

Podiatrist, Foot & Ankle Surgery Parma, OH Doctor of Podiatric Medicine

NPI 1295090470 CMS profile 149013

6688 Ridge Rd Ste 1110, Parma, OH 44129

Open in the dashboard

General payments

$11,764

151 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Mark Razzante of Parma, OH is reported in the CMS Open Payments database as having received $11,764 across 151 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 86th percentile of Podiatrist, Foot & Ankle Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $200 3
2024 General $400 8
2023 General $1,027 15
2022 General $1,740 28
2021 General $3,202 36
2020 General $1,895 22
2019 General $3,300 39

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Mark Razzante
  • Podiatrist, Foot & Ankle Surgery median
  • Middle half of Podiatrist, Foot & Ankle Surgery
  • National median

In program year 2025, general payments to Mark Razzante were reported at $200. Among 6,994 Podiatrist, Foot & Ankle Surgery profiles paid that year, the median was $424 and the middle half received between $139 and $1,306.

Show as a table
Year Mark Razzante Podiatrist, Foot & Ankle Surgery median Middle half National median
2019 $3,300 $389 $118–$1,406 $163
2020 $1,895 $191 $62–$691 $114
2021 $3,202 $329 $104–$1,341 $132
2022 $1,740 $419 $125–$1,611 $149
2023 $1,027 $377 $128–$1,164 $160
2024 $400 $394 $134–$1,168 $164
2025 $200 $424 $139–$1,306 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Arthrosurface Incorporated $3,271 5 payments
  2. Stryker Corporation $3,184 45 payments
  3. Integra LifeSciences Corporation $1,505 27 payments
  4. Treace Medical Concepts, Inc. $1,448 16 payments
  5. Anika Therapeutics, Inc. $889 2 payments
  6. Smith+Nephew, Inc. $377 22 payments
  7. Orthofix Medical, Inc. $162 2 payments
  8. Kerecis Limited $151 2 payments
  9. Paragon 28, Inc. $123 3 payments
  10. Medtronic Vascular, Inc. $72 1 payment
  11. Other $583 26 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $5,806 142 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $2,500 2 payments
  3. Travel and Lodging $2,432 5 payments
  4. Education $1,026 2 payments
Products named General payments · program years 2019–2025
  1. HemiCAP MTP Resurfacing $3,271 5 payments
  2. Lapiplasty System $1,119 8 payments
  3. INFINITY $1,026 2 payments
  4. INBONE $897 2 payments
  5. OVO $860 1 payment
  6. AMNIOEXCEL $680 14 payments
  7. TCC-EZ $642 12 payments
  8. PRIMATRIX $642 12 payments
  9. MEDIHONEY $642 12 payments
  10. OMNIGRAFT $642 12 payments
  11. Other $8,504 182 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

151 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Podiatrist, Foot & Ankle Surgery in Ohio

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record